IRIS
PICARDI, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.855
EU - Europa 2.681
AS - Asia 1.118
SA - Sud America 28
Continente sconosciuto - Info sul continente non disponibili 8
AF - Africa 5
OC - Oceania 4
Totale 32.699
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.738
DE - Germania 843
SG - Singapore 494
UA - Ucraina 400
CN - Cina 379
IE - Irlanda 307
IT - Italia 280
GB - Regno Unito 255
RU - Federazione Russa 222
CA - Canada 114
KR - Corea 99
FR - Francia 96
SE - Svezia 93
FI - Finlandia 79
HK - Hong Kong 67
PL - Polonia 49
JP - Giappone 17
BR - Brasile 16
UZ - Uzbekistan 16
BE - Belgio 13
CZ - Repubblica Ceca 7
ES - Italia 7
IN - India 7
AT - Austria 6
NL - Olanda 6
VN - Vietnam 6
CL - Cile 5
EU - Europa 5
IR - Iran 5
AU - Australia 4
CH - Svizzera 4
GR - Grecia 4
ID - Indonesia 4
KG - Kirghizistan 4
MY - Malesia 4
PH - Filippine 4
RO - Romania 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AR - Argentina 3
PE - Perù 3
BG - Bulgaria 2
DK - Danimarca 2
MA - Marocco 2
MX - Messico 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
DM - Dominica 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
IL - Israele 1
JO - Giordania 1
KW - Kuwait 1
LT - Lituania 1
MU - Mauritius 1
NP - Nepal 1
OM - Oman 1
TH - Thailandia 1
TN - Tunisia 1
TR - Turchia 1
TW - Taiwan 1
Totale 32.699
Salva come PNG Salva come JPEG
Città #
Woodbridge 8.229
Wilmington 8.054
Houston 7.034
Fairfield 868
Ann Arbor 762
Chandler 490
Ashburn 457
Singapore 412
Seattle 356
Jacksonville 334
Cambridge 287
Dublin 281
Medford 218
Dearborn 198
Munich 140
Beijing 136
Rome 122
New York 117
Mcallen 112
Montréal 110
Lawrence 105
Santa Clara 105
Zhengzhou 89
Hong Kong 67
Moscow 52
San Diego 49
Kraków 46
Menlo Park 38
Mülheim 35
London 21
Los Angeles 20
Milan 19
Kunming 18
Norwalk 17
Falls Church 16
Nürnberg 15
San Mateo 15
University Park 15
Bologna 14
Shanghai 14
Brussels 13
Nanjing 13
Hefei 12
Helsinki 11
Saint Petersburg 11
Palo Alto 10
Boardman 9
San Francisco 9
Nanchang 8
Verona 8
Fuzhou 7
Hounslow 7
Mountain View 7
Redmond 7
Redwood City 7
Seoul 7
Brno 6
Creede 6
Guangzhou 6
Hebei 6
Chengdu 5
Chicago 5
Clearwater 5
Nuremberg 5
Prescot 5
Rieti 5
Washington 5
Center 4
Changsha 4
Dong Ket 4
Indiana 4
Jakarta 4
Jinan 4
Kuala Lumpur 4
Manila 4
Shenyang 4
Toronto 4
Vienna 4
Auburn Hills 3
Chiswick 3
Chongqing 3
Frankfurt am Main 3
Kilburn 3
Latina 3
Lima 3
Pars 3
Shaoxing 3
São Paulo 3
Tokyo 3
Turin 3
Acton 2
Amsterdam 2
Banbridge 2
Baotou 2
Canberra 2
Chaoyang 2
Clifton 2
Council Bluffs 2
Engelhard 2
Enterprise 2
Totale 29.792
Salva come PNG Salva come JPEG
Nome #
Awake thoracoscopic biopsy of anterior mediastinal masses 832
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor 497
Enumeration of CD34+ hematopoietic progenitor cells for clinical transplantation: comparison of three different methods 480
Enumeration of CD34+ hematopoietic progenitor cells for clinical transplantation: comparison of three different methods 469
Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation 456
Acute foetal distress and umbilical cord blood banking 439
High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network. 439
Bowel ultrasonography as an aid for diagnosis of intestinal acute graft-versus-host-disease after allogeneic haematopoietic stem cell transplantation 438
Hematopoietic, Mesenchymal, and Immune Cells Are More Enhanced in Bone Marrow than in Peripheral Blood from Granulocyte Colony-Stimulating Factor Primed Healthy Donors 435
Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation 431
Analysis of the expression of adhesion molecules on CD34+ progenitors from bone marrow, umbilical cord blood and G-CSF mobilized peripheral blood 430
Placental/Umbilical cord blood: experience of St. Eugenio Hospital collection center 425
A phase II study of VP-16, intermediate-dose Ara-C and carboplatin (VAC) in advanced acute myelogenous leukemia and blastic chronic myelogenous leukemia 423
Excretion of the novel polyomaviruses KI and WU in the stool of patients with hematological disorders 415
Cord blood transplantation in adults with acute myeloid leukaemia. 414
Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation 414
Randomized comparison of awake nonresectional versus nonawake resectional lung volume reduction surgery. 411
The therapeutic use of cord blood 410
Pre-transplant manipulation processing of umbilical cord blood units: Efficacy of Rubinstein's thawing technique used in 40 transplantation procedures 409
A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient 406
Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion 406
A new system for quality control in hematopoietic progenitor cell units before reinfusion in autologous transplant. 406
Platelet gel for treatment of mucocutaneous lesions related to graft-versus-host disease after allogeneic hematopoietic stem cell transplant. 400
The potential role of pre-transplant HBcIgG seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: A study from the Rome Transplant Network 400
Unrelated Cord Blood transplantaion for children with high risk myelodysplastic syndrome 398
Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and/or systemic fungal infection 396
Haploidentical, unmanipulated,G-CSF primed bona marrow transplantation for patients with high risk hematological malignancies 395
The policy of the Rome Transplant Network (RTN), a metropolitan (2009). The Potential Application Of The Allogeneic Transplant By The Policy Of Widespread Donor Search: An Intention-To-Treat Analysis From The Rome Transplant Network. 392
Quality assessment of cord blood units selected for unrelated transplantation: a transplant center perspective 391
Breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis [6] 390
Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia 386
Platelet gel for treatment of mucocutaneous lesions related to graft-versus-host disease after allogeneic hematopoietic stem cell transplant 384
Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation 382
Zoledronic acid-associated thrombotic thrombocytopenic purpura [1] 381
Nonmyeloablative allogeneic blood stem cell transplantation in patients with metastatic solid tumors 380
Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositis 380
Controversies on antibiotic lock technique duration: experience with a 3-day course for hematological patients 380
Red blood cell depletion and cryopreservation of umbilical cord blood (UCB) 377
Reduced intensity allogeneic transplantation in primary cutaneous t-cell lymphomas. 373
Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies 372
Algorithm for donor selection in 2011 371
breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis 370
The Rome Transplant Network model compared to the Italian Bone Marrow Donor Registry activity for unrelated donor search process and transplant efficiency for hematologic malignancy 370
The potential role of pre-transplant HBcIgG seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: A study from the Rome Transplant Network. 368
Diagnosis of acute foetal distress does not preclude banking of umbilical cord blood units 365
A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 365
Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies 363
Retinoic acid and arsenic trioxide sensitize acute promyelocytic leukemia cells to ER stress 363
Factors Associated with Long-Term Risk of Relapse after Unrelated Cord Blood Transplantation in Children with Acute Lymphoblastic Leukemia in Remission 361
Quantitative analysis of Fas and bcl-2 expression in hematopoietic precursors 360
Outcomes of allogeneic stem cell transplantation for secondary therapy-related acute myeloid leukaemia 359
Umbilical Cord Blood Transplantation From Unrelated Donors In Patients With Ph-Positive Acute Lymphoblastic Leukemia. 356
Up-regulation of activating and inhibitory NKG2 receptors in allogeneic and autologous hematopoietic stem cell grafts 354
Impact of Graft-versus-Host Disease Prophylaxis on Outcomes after Myeloablative Single-Unit Umbilical Cord Blood Transplantation 349
The forkhead box C1 (FOXC1) transcription factor is downregulated in acute promyelocytic leukemia 347
Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia: a survey on behalf of Eurocord and CLWP of EBMT. 346
Extracorporeal photochemotherapy in the treatment of acute and chronic GvHD: experience from Rome Transplant Network 341
Platelet gel is highly effective in treating muco-cutaneous lesions related to graft-versus-host disease 340
CD34-positive cells in human umbilical cord blood express nerve growth factor and its specific receptor TrkA 339
Allogeneic stem cell transplantation for patients with advanced primary cutaneous T-cell lymphoma 339
Organizzazione e attività delle Banche di sangue placentare 337
Successful treatment of disseminated fusariosis with high dose liposomal amphotericin-B in a patient with acute lymphoblastic leukemia [4] 337
Identification of the novel allele, HLA-A*02:653, in an Italian patient 337
BK virus DNA detection by real-time polymerase chain reaction in clinical specimens 332
Reduced-intensity conditioning combined with standard GvHD prophylaxis is tolerable and highly effective for patients with primary cutaneous T-cell lymphomas undergoing allogeneic transplantation in advanced disease stage. 331
Excretion of the novel polyomaviruses KI and WU in the stool of patients with hematological disorders 327
Quality controls of cord blood units according to JACIE standards are highly predictive in unrelated cord blood transplant 326
Fibrin glue therapy for severe hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation 323
Fibrin glue directly applied on damaged bladder mucosa during cystoscopy is highly effective to treat severe, refractory, haemorrhagic cystitis after allogeneic transplant 321
Extracorporeal photopheresis as first-line treatment in high-risk graft-versus-host disease 318
Impact of HLA mismatch direction on outcome after umbilical cord blood transplantation for hematological malignant disorders: a retrospective eurocord-EBMT analysis. 318
Allogeneic hematopoietic stem cell transplantation in Primary Cutaneous T Cell Lymphoma 316
Il Trapianto di Cellule Stminali Emopoietiche. 305
Unmanipulated bone marrow transplantation from haplo-identical related donor for patients with high-risk haematological malignancies 290
Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia after Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey 289
Analysis of the expression of adhesion molecules on CD34+ progenitors from bone marrow, umbilical cord and G-CSF stimulated peripheral blood 283
Access to alternative donor hematopoietic search and transplantation for acute leukemia in different macro-regions of Italy. A GITMO/IBMDR study 275
The Potential Application of the Allogeneic Transplant by the Policy of Widespread Donor Search: an Intention- To-Treat Analysis from the Rome Transplant Network . 263
The potential application of the allogeneic transplant according to a widespread donor search policy: an intention-to-treat analysis from the Rome Transplant Network 262
Gemtuzumab ozogamicin in combination with intensive chemotherapy for relapsed/refractory acute myeloid leukemia 241
Umbilical cord blood transplantation in adults with advanced hodgkin's disease: high incidence of post-transplant lymphoproliferative disease 223
WT1 evaluation in higher-risk myelodysplastic syndrome patients treated with azacitidine 185
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 178
Haploidentical, G-CSF-primed, unmanipulated bone marrow transplantation for patients with high-risk hematological malignancies: an update 173
Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia 146
MATCHED-PAIR ANALYSIS OF TRANSPLANT FROM HAPLOIDENTICAL, UNMANIPULATED BONE MARROW DONOR VERSUS HLA IDENTICAL SIBLING FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES 143
Retinoic acid synergizes with the unfolded protein response and oxidative stress to induce cell death in FLT3-ITD+ AML 139
Quality assessment of cord blood units selected for unrelated transplantation: a transplant center perspective 138
Pre-transplant manipulation processing of umbilical cord blood units: Efficacy of Rubinstein's thawing technique used in 40 transplantation procedures 135
A new system for quality control in hematopoietic progenitor cell units before reinfusion in autologous transplant 134
Is outcome of older people with acute myeloid leukemia improving with new therapeutic approaches and stem cell transplantation? 133
Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositis 132
Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies 126
Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation 125
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO) 125
Is there still a role for autologous stem cell transplantation for the treatment of acute myeloid leukemia? 119
Impact of graft-versus-host disease prophylaxis on outcomes after myeloablative single-unit umbilical cord blood transplantation 113
Umbilical cord blood transplantation from unrelated donors in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia 113
Cerebellar Neurocysticercosis as Long-Term Complication of Allogeneic Haematopoietic Stem Cell Transplantation from Haploidentical Donor 111
Allelic HLA matching and pair origin are favorable prognostic factors for unrelated hematopoietic stem cell transplantation in neoplastic hematologic diseases: an Italian analysis by the Gruppo italiano trapianto di cellule staminali e terapie cellulari, Italian bone marrow donor registry, and Associazione Italiana di immunogenetica e biologia dei trapianti 42
Totale 32.832
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.543
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.543
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.643 0 0 0 0 0 0 851 765 814 814 727 672
2020/20215.414 641 616 600 682 515 655 657 493 140 149 217 49
2021/20221.005 30 134 48 38 26 72 72 56 51 99 77 302
2022/20231.258 154 111 56 162 78 304 100 79 113 6 69 26
2023/2024469 52 10 27 9 53 140 38 12 14 3 1 110
2024/20251.048 83 472 205 139 48 101 0 0 0 0 0 0
Totale 32.990